ELAN Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals in the United States and internationally. It offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and food animal products used in ruminant and swine production. The company caters to veterinarians and food producers of countries in North America, South America, Asia-Pacific, Europe, the Middle East, and Africa. Elanco Animal Health Incorporated was founded in 1954 and is based in Greenfield, Indiana. Elanco Animal Health Incorporated operates as a subsidiary of Eli Lilly and Company.

$32.10  -0.44 (-1.35%)
As of 10/18/2021 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  09/20/2018
Outstanding shares:  473,019,117
Average volume:  2,995,582
Market cap:   $15,349,470,347
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    28414H103
ISIN:        US28414H1032
Valuation   (See tab for details)
PE ratio:   -21.12
PB ratio:   1.93
PS ratio:   3.37
Return on equity:   -9.13%
Net income %:   -16.02%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy